BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24332572)

  • 1. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
    Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
    Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.
    Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC
    J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.
    Zhou J; Yu L; Gao X; Hu J; Wang J; Dai Z; Wang JF; Zhang Z; Lu S; Huang X; Wang Z; Qiu S; Wang X; Yang G; Sun H; Tang Z; Wu Y; Zhu H; Fan J
    J Clin Oncol; 2011 Dec; 29(36):4781-8. PubMed ID: 22105822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients.
    Sakai Y; Honda M; Fujinaga H; Tatsumi I; Mizukoshi E; Nakamoto Y; Kaneko S
    Cancer Res; 2008 Dec; 68(24):10267-79. PubMed ID: 19074895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New genetic markers for diagnosis of hepatitis C related hepatocellular carcinoma in Egyptian patients.
    Saad Y; El-Serafy M; Eldin MS; Abdellatif Z; Khatab H; Elbaz T; Elgarem H
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):419-25. PubMed ID: 24369324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
    Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
    Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression and clinical significance of chemokine receptor CXCR2 in hepatocellular carcinoma.
    Liu Z; Yang L; Xu J; Zhang X; Wang B
    J Surg Res; 2011 Apr; 166(2):241-6. PubMed ID: 20018298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.
    Wang W; Zhao LJ; Wang Y; Tao QY; Feitelson MA; Zhao P; Ren H; Qi ZT
    Cancer Biomark; 2011-2012; 11(1):29-39. PubMed ID: 22820138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Applicability of the multiplex quantitative antibody array system for early diagnosis of hepatocellular carcinoma].
    Gao DM; Sun L; Guo K; Li Y; Liu YK; Kang XN
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):785-8. PubMed ID: 23207342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
    Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.
    Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY
    Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genes expression profiling of peripheral blood cells of patients with hepatocellular carcinoma.
    Zhang PJ; Wei R; Wen XY; Ping L; Wang CB; Dong ZN; Deng XX; Bo W; Bin C; Tian YP
    Cell Biol Int; 2012 Sep; 36(9):803-9. PubMed ID: 22582734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.